Beyond mere diversity: Tailoring combinatorial libraries for drug discovery

被引:138
作者
Martin, EJ
Critchlow, RE
机构
[1] Chiron Corp, Emeryville, CA 94608 USA
[2] Daylight Chem Informat Syst Inc, Santa Fe, NM 87501 USA
来源
JOURNAL OF COMBINATORIAL CHEMISTRY | 1999年 / 1卷 / 01期
关键词
D O I
10.1021/cc9800024
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Combinatorial Library design attempts to choose the best set of substituents for a combinatorial synthetic scheme to maximize the chances of finding a useful compound, such as a drug lead, initial efforts were focused primarily on maximizing diversity, perhaps allowing some bias by the inclusion of a small, fixed set of pharmacophoric substituents. However, many factors besides diversity impact good library design for drug discovery. A Library can be better "tailored" by assigning the candidate substituents to categories such as polar, pharmacophoric, rigid, low molecular weight, and expensive. Stratified sampling by successive steps of D-optimal design generates diverse designs which are also consistent with desirable profiles of these properties. Comparing the diversity scores among design profiles reveals the tradeoffs between diversity, physical property distributions, synthetic difficulty, expense, and pharmacophoric bias. The diversity scores can be calibrated by scoring the best designs from subsets of the candidates made either from specific classes of substituents or by randomly eliminating candidates. This procedure shows how poor random designs are compared even to highly biased optimal designs. Library design requires a synergistic effort between computational and synthetic medicinal chemists, so specialized interactive software has been developed to integrate substructure searching, display, and statistical experimental design to facilitate this interaction for the effective design of well-tailored libraries.
引用
收藏
页码:32 / 45
页数:14
相关论文
共 27 条
[1]  
[Anonymous], 1972, THEORY OPTIMAL EXPT
[2]  
AUSTEL V, 1995, METH PRIN MED CHEM, V2, P49
[3]   A DIFFICULTY INFORMATION APPROACH TO SUBSTITUENT SELECTION IN QSAR STUDIES [J].
BORTH, DM ;
MCKAY, RJ ;
ELLIOTT, JR .
TECHNOMETRICS, 1985, 27 (01) :25-35
[4]  
BRANNIGAN LH, 1995, CHEMTECH, V25, P225
[5]   THE INFLUENCE OF PEPTIDE STRUCTURE ON TRANSPORT ACROSS CACO-2 CELLS .2. PEPTIDE-BOND MODIFICATION WHICH RESULTS IN IMPROVED PERMEABILITY [J].
CONRADI, RA ;
HILGERS, AR ;
HO, NFH ;
BURTON, PS .
PHARMACEUTICAL RESEARCH, 1992, 9 (03) :435-439
[6]  
Dillon W.R., 1984, MULTIVARIATE ANAL ME
[7]   A SIMPLE BAYESIAN MODIFICATION OF D-OPTIMAL DESIGNS TO REDUCE DEPENDENCE ON AN ASSUMED MODEL [J].
DUMOUCHEL, W ;
JONES, B .
TECHNOMETRICS, 1994, 36 (01) :37-47
[8]   Optimization and visualization of molecular diversity of combinatorial libraries [J].
Hassan, M ;
Bielawski, JP ;
Hempel, JC ;
Waldman, M .
MOLECULAR DIVERSITY, 1996, 2 (1-2) :64-74
[9]   USE OF EXPERIMENTAL-DESIGN IN THE PHARMACEUTICAL-INDUSTRY [J].
KETTANEHWOLD, N .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1991, 9 (08) :605-610
[10]  
Linger S.H., 1980, DRUG DESIGN, V9, P47